ROYCE & ASSOCIATES LP - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 121 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$5,0000.0%537
+54.8%
0.00%
Q4 2017$5,0000.0%347
+40.5%
0.00%
Q3 2017$5,0002470.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$10,515,00010.70%
Orchard Capital Management, LLC 1,593,531$3,601,0001.06%
Nantahala Capital Management 4,918,565$11,116,0000.39%
Ardent Capital Management, Inc. 168,811$382,0000.25%
Birchview Capital, LP 100,000$226,0000.15%
Nantahala Capital Management 1,000,000$2,260,0000.08%
PDT Partners, LLC 433,400$979,0000.08%
Woodline Partners LP 2,231,966$5,044,0000.07%
Virtus ETF Advisers LLC 69,015$156,0000.06%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,737,900$6,188,0000.04%
View complete list of AKEBIA THERAPEUTICS INC shareholders